Section 5: Patient Safety and Quality Assurance

5PSQ-002

HYPOMAGNESAEMIA ALERT! MONITOR CLOSELY THE PROTON PUMP INHIBITORS FOR CHRONIC TREATMENT IN ELDERLY PATIENTS (submitted in 2019)

5PSQ-001

PHARMACIST INTERVENTION TO IMPROVE THE SAFETY OF PATIENTS TREATED WITH PROTON PUMP INHIBITORS (submitted in 2019)

5PSQ-165

QUALITY CONTROL OF INFUSIONS IN PATIENT-SPECIFIC PREPARATIONS FOR ONCOLOGICAL TREATMENT

5PSQ-164

DRUG-DRUG INTERACTIONS IN PATIENTS WITH CARDIOVASCULAR DISEASES

5PSQ-163

MEDICATION RECONCILIATION IN AN EMERGENCY DEPARTMENT

5PSQ-162

ABSTRACT WITHDRAWN

5PSQ-161

SECURING STORAGE OF HIGH-RISK MEDICINES IN A CARE UNIT: WHERE ARE WE NOW?

5PSQ-160

MEDICATION RECONCILIATION IN THE EMERGENCY DEPARTMENT IN ELDERLY PATIENTS

5PSQ-159

KEY POINTS IN IMPROVING THE RECONCILIATION PROCESS IN AN EMERGENCY DEPARTMENT

5PSQ-158

INTEREST IN MEDICATION RECONCILIATION AND ESTABLISHMENT OF A PRIORITISATION SCORE IN A VASCULAR SURGERY DEPARTMENT

5PSQ-157

IMPACT OF ANTICHOLINERGIC BURDEN, QUANTIFIED BY ANTICHOLINERGIC RISK SCALES, ON COGNITIVE AND FUNCTIONAL STATUS AND FALLS IN PATIENTS WITH MULTIMORBIDITY: A PRELIMINARY STUDY

5PSQ-156

RISK ASSESSMENT AND MANAGEMENT TO IMPROVE THERMO-SENSITIVE DRUGS SAFETY

5PSQ-155

THE EFFECT OF GERIATRIC STEWARDSHIP ON DRUG-RELATED PROBLEMS AFTER DISCHARGE

5PSQ-154

INCIDENT REPORTS VERSUS DIRECT OBSERVATION TO IDENTIFY MEDICATION ERRORS AND RISK FACTORS IN HOSPITALISED NEWBORNS

5PSQ-153

DETECTION OF POTENTIALLY INAPPROPRIATE PRESCRIBING IN AN INSTITUTIONALISED POPULATION

Pages